Intercure Ltd. (INCR) Financials

INCR Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 228.2 million 85.2 million
2023-03-31 266.2 million 121.3 million
2022-12-31 248.6 million 100.1 million
2022-09-30 246.1 million 101.7 million

INCR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 257221 257221
2023-03-31 10.7 million 759882
2022-12-31 10.9 million 776545
2022-09-30 270099 1.0 million

INCR Net Income

No data available :(

INCR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 27.9 million - 5.8 million
2023-03-31 64.7 million - 6.2 million
2022-12-31 30.3 million - 7.8 million
2022-09-30 60.6 million - 5.5 million

INCR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 11.6 million
2023-03-31 12.6 million
2022-12-31 12.9 million
2022-09-30 12.8 million

INCR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 1031 26833 3.1 million 3.9 million
2023-03-31 1.3 million 48343 16.2 million 9.8 million
2022-12-31 1.3 million 49403 16.6 million 10.0 million
2022-09-30 1.2 million 33762 3.9 million 4.7 million

INCR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 27.8 million 18.9 million
2023-03-31 29.3 million 22.2 million
2022-12-31 30.0 million 22.6 million
2022-09-30 28.3 million 15.3 million

INCR

Price: $2.66

52 week price:
0.99
2.92

Earnings Per Share: 0.12 USD

P/E Ratio: 12

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 6941

Ebitda: 98.4 million

Market Capitalization: 107.6 million

Links: